Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)

China flag China · Delayed Price · Currency is CNY
29.24
-0.05 (-0.17%)
At close: Feb 27, 2026
Market Cap3.70B +8.9%
Revenue (ttm)367.49M -11.5%
Net Income-47.39M
EPS-0.40
Shares Out126.54M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,551,744
Average Volume4,262,190
Open29.30
Previous Close29.29
Day's Range29.10 - 29.49
52-Week Range23.20 - 41.50
Beta-0.78
RSI47.26
Earnings DateMar 28, 2026

About SHE:301089

Tuoxin Pharmaceutical Group Co.,Ltd. engages in the research and development, production and sales of nucleoside (acid) APIs and pharmaceutical intermediates in China. It offers nucleoside (acid) products, such as pyrimidine series, purine series, and nucleotide series; nucleoside series, including citicoline sodium, ribavirin, inosine, acyclovir, azithromycin, cytosine, 5-fluorocytosine, cytidine, uridine; and other APIs and pharmaceutical intermediates covering antiviral, anti-tumor, and nervous system. The company was founded in 2001 and is ... [Read more]

Sector Healthcare
Founded 2001
Employees 1,551
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301089
Full Company Profile

Financial Performance

Financial Statements